A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

P. Serruys,V. Farooq,P. Vranckx,C. Girasis,S. Brugaletta,H. Garcia-Garcia,D. Holmes,A. Kappetein,M. Mack,T. Feldman,M. Morice,E. Ståhle,S. James,A. Colombo,Peggy Pereda,Jian Huang,M. Morel,G. van Es,K. Dawkins,F. Mohr,E. Steyerberg

Published 2012 in JACC: Cardiovascular Interventions

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-59 of 59 references · Page 1 of 1

CITED BY

Showing 1-100 of 105 citing papers · Page 1 of 2